Showing results (111-120 of 319) with videos related to
Sort By:
Pageof 32
Cancer|July 28, 2009
Docetaxel and irinotecan in recurrent or metastatic head and neck cancer: a phase 2 trial of the Eastern Cooperative Oncology GroupAthanassios Argiris, Ashley Buchanan, Bruce Brockstein, et al.Clinical Lung Cancer|May 27, 2008
Cooperative group portfolio in locally advanced non-small-cell lung cancer: are we making progress?Corey J Langer, Heather Wakelee, Joan Schiller, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|May 30, 2013
A pooled analysis of limited-stage small-cell lung cancer patients treated with induction chemotherapy followed by concurrent platinum-based chemotherapy and 70 Gy daily radiotherapy: CALGB 30904Joseph K Salama, Lydia Hodgson, Herbert Pang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 3, 2016
Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE)Joseph K Salama, Lin Gu, Xiaofei Wang, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 25, 2018
Exploring Radiotherapy Targeting Strategy and Dose: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Stage III NSCLCSteven E Schild, Herbert H Pang, Wen Fan, et al.Clinical Lung Cancer|August 16, 2005
Induction paclitaxel/carboplatin followed by concurrent chemoradiation therapy for unresectable stage III non-small-cell lung cancer: a limited-access study--CALGB 9534Wallace Akerley, James E Herndon, Alan P Lyss, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 8, 2018
Toxicity Related to Radiotherapy Dose and Targeting Strategy: A Pooled Analysis of Cooperative Group Trials of Combined Modality Therapy for Locally Advanced Non-Small Cell Lung CancerSteven E Schild, Wen Fan, Thomas E Stinchcombe, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 19, 2010
Phase II study of Cediranib (AZD 2171), an inhibitor of the vascular endothelial growth factor receptor, for second-line therapy of small cell lung cancer (National Cancer Institute #7097)Suresh S Ramalingam, Chandra P Belani, Philip C Mack, et al.Clinical Lung Cancer|December 10, 2003
Phase I study of dose-dense alternating doublets in advanced non-small-cell lung cancerEverett E Vokes, Chaiyut Charoentum, Gary S Gordon, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 27, 2020
Couple-based communication intervention for head and neck cancer: a randomized pilot trialTina M Gremore, Bruce Brockstein, Laura S Porter, et al.Pageof 32